Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity

This publication has 70 references indexed in Scilit:

• Use of intensity quotients and differences in absolute structure refinement
  Acta crystallographica Section B, Structural science, crystal engineering and materials, 2013
• Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity
  European Journal of Medicinal Chemistry, 2013
• Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
  Lung Cancer, 2012
• Influence of methoxy groups on the antiproliferative effects of [FeIII(salophene-OMe)Cl] complexes
  European Journal of Medicinal Chemistry, 2010
• Advances in Cancer Therapeutics
  Clinical Pharmacology & Therapeutics, 2009
• Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells
  PLOS ONE, 2008
• Studies on anticancer activities of antimicrobial peptides
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2008
• A short history of SHELX
  Acta Crystallographica Section A Foundations of Crystallography, 2007
• Molecular mechanisms of resistance and toxicity associated with platinating agents
  Cancer Treatment Reviews, 2007
• Knigth′s Move in the Periodic Table, From Copper to Platinum,Novel Antitumor Mixed Chelate Copper Compounds, Casiopeinas,Evaluated by an in Vitro Human and Murine Cancer Cell Line Panel
  Metal-Based Drugs, 2001